Active Pharmaceutical Ingredients Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

  • ID: 4590669
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 4

FEATURED COMPANIES

  • Actavis plc
  • BASF SE
  • Dr. Reddy's Laboratories
  • Hospira Inc.
  • Lonza Group AG
  • Mylan N.V.
  • MORE
The report on global active pharmaceutical ingredients market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global active pharmaceutical ingredients market to grow with a CAGR of 5.4% over the forecast period of 2018-2024. The study on active pharmaceutical ingredients market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

The global Active Pharmaceutical Ingredient (API) market size was valued at USD XX billion in the year 2017 and is estimated to reach a value of USD XX billion by 2024, The major factors driving responsible for driving the market growth are, rising incidences of oncology, cardiovascular, diabetes and lifestyle diseases, rising geriatric population in developing countries and increasing disease awareness. However cost of improving process design and stringent FDA regulations & approvals to hinder the active pharmaceutical growth opportunities. Development of new innovative API’s and inorganic growth through mergers and acquisition too further boost the API market.

Among the geographies, North America accounted for the highest market share in 2017. U.S drives the North America API market on account of presence of major pharmaceutical companies, these companies are constantly involved in development of new API’s for treating various diseases. North America is followed by Europe and Asia Pacific.

The report on active pharmaceutical ingredients market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global active pharmaceutical ingredients market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global active pharmaceutical ingredients market over the period of 2016 to 2024. Further, the Growth Matrix h Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents.

The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through:

1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

Secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segments Covered

The global active pharmaceutical ingredients market is segmented on the basis of api type, drug type and application.

Global Active Pharmaceutical Ingredients Market by API Type
  • Chemical API
  • Biological API
Global Active Pharmaceutical Ingredients Market by Drug Type
  • Generic Prescription Drugs
  • OTC Prescription Drugs
Global Active Pharmaceutical Ingredients Market by Application
  • Cardiovascular Disease
  • Oncology
  • CNS And Neurological Disorders
  • Orthopedic Disorders
  • Endocrinology
  • Gastrointestinal Disorders
  • Ophthalmology
  • Pulmonology
  • Others
Company Profiles
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Dr. Reddy's Laboratories
  • Actavis plc
  • Lonza Group AG
  • Hospira Inc.
  • BASF SE
How this report delivers

1. Comprehensive analysis of global as well as regional markets of active pharmaceutical ingredients market.

2. Complete coverage of all the segments in active pharmaceutical ingredients market to analyze the trends, developments in the global market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in global active pharmaceutical ingredients market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Actavis plc
  • BASF SE
  • Dr. Reddy's Laboratories
  • Hospira Inc.
  • Lonza Group AG
  • Mylan N.V.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary

3. Global Active Pharmaceutical Ingredients Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.5. Competitive Landscape in the Global Active Pharmaceutical Ingredients Market

4. Global Active Pharmaceutical Ingredients Market by API Type
4.1. Chemical API
4.2. Biological API

5. Global Active Pharmaceutical Ingredients Market by Drug Type
5.1. Generic Prescription Drugs
5.2. OTC Prescription Drugs

6. Global Active Pharmaceutical Ingredients Market by Application
6.1. Cardiovascular Disease
6.2. Oncology
6.3. CNS And Neurological Disorders
6.4. Orthopedic Disorders
6.5. Endocrinology
6.6. Gastrointestinal Disorders
6.7. Ophthalmology
6.8. Pulmonology
6.9. Others

7. Global Active Pharmaceutical Ingredients Market by Region 2018-2024
7.1. North America
7.1.1. North America Active Pharmaceutical Ingredients Market by API Type
7.1.2. North America Active Pharmaceutical Ingredients Market by Drug Type
7.1.3. North America Active Pharmaceutical Ingredients Market by Application
7.1.4. North America Active Pharmaceutical Ingredients Market by Country
7.2. Europe
7.2.1. Europe Active Pharmaceutical Ingredients Market by API Type
7.2.2. Europe Active Pharmaceutical Ingredients Market by Drug Type
7.2.3. Europe Active Pharmaceutical Ingredients Market by Application
7.2.4. Europe Active Pharmaceutical Ingredients Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Active Pharmaceutical Ingredients Market by API Type
7.3.2. Asia-Pacific Active Pharmaceutical Ingredients Market by Drug Type
7.3.3. Asia-Pacific Active Pharmaceutical Ingredients Market by Application
7.3.4. Asia-Pacific Active Pharmaceutical Ingredients Market by Country
7.4. RoW
7.4.1. RoW Active Pharmaceutical Ingredients Market by API Type
7.4.2. RoW Active Pharmaceutical Ingredients Market by Drug Type
7.4.3. RoW Active Pharmaceutical Ingredients Market by Application
7.4.4. RoW Active Pharmaceutical Ingredients Market by Sub-region

8. Company Covered
8.1. Novartis Ag
8.2. Sun Pharmaceutical Industries Ltd
8.3. Pfizer, Inc.
8.4. Teva Pharmaceutical Industries Ltd.
8.5. Mylan N.V.
8.6. Dr. Reddy's Laboratories
8.7. Actavis Plc
8.8. Lonza Group Ag
8.9. Hospira Inc.
8.10. Basf Se
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Dr. Reddy's Laboratories
  • Actavis plc
  • Lonza Group AG
  • Hospira Inc.
  • BASF SE
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll